1. Silver-nanoparticles increase bactericidal activity and radical oxygen responses against bacterial pathogens in human osteoclasts.
- Author
-
Aurore V, Caldana F, Blanchard M, Kharoubi Hess S, Lannes N, Mantel PY, Filgueira L, and Walch M
- Subjects
- Anti-Bacterial Agents chemistry, Cells, Cultured, Humans, Metal Nanoparticles chemistry, Osteoclasts pathology, Phagocytosis, Staphylococcal Infections microbiology, Staphylococcus aureus isolation & purification, Anti-Bacterial Agents administration & dosage, Metal Nanoparticles administration & dosage, Osteoclasts drug effects, Reactive Oxygen Species metabolism, Silver chemistry, Staphylococcal Infections drug therapy, Staphylococcus aureus drug effects
- Abstract
Bone infections are difficult to treat and can lead to severe tissue destruction. Acute bone infections are usually caused by Staphylococcus aureus. Osteoclasts, which belong to the monocyte/macrophage lineage, are the key cells in bone infections. They are not well equipped for killing bacteria and may serve as a reservoir for bacterial pathogens. Silver has been known for centuries for its bactericidal activity. Here, we investigated the bactericidal effects of nano-silver particles in bacteria infected human osteoclasts. We found that nano-silver in per se non-toxic concentration enhanced the bactericidal activity in osteoclasts against intracellular Methicillin-resistant, virulent Staphylococcus aureus. The reduced bacterial survival in nano-silver pretreated cells correlated with increased reactive oxygen responses towards the invading pathogens. Overall, these results indicate that nano-silver compounds should be considered as an effective treatment and prevention option for bacterial bone and orthopedic implant infections., (Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF